{{Rsnum
|rsid=2084881
|Gene=SKAP1
|Chromosome=17
|position=48279758
|Orientation=plus
|GMAF=0.3104
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SKAP1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 9.0 | 38.7 | 52.3
| HCB | 2.2 | 28.9 | 68.9
| JPT | 3.5 | 29.2 | 67.3
| YRI | 32.7 | 43.5 | 23.8
| ASW | 15.8 | 45.6 | 38.6
| CHB | 2.2 | 28.9 | 68.9
| CHD | 3.8 | 21.7 | 74.5
| GIH | 2.0 | 33.7 | 64.4
| LWK | 34.9 | 47.7 | 17.4
| MEX | 10.5 | 35.1 | 54.4
| MKK | 15.4 | 53.2 | 31.4
| TSI | 5.9 | 39.2 | 54.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20852632
|Trait=None
|Title=A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
|RiskAllele=
|Pval=0.000002
|OR=1.12
|ORtxt=[1.07-1.18]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}